COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • November 2nd, 2011 • Array Biopharma Inc • Pharmaceutical preparations • England and Wales
THIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is made effective as of the 12 day of July, 2011 (“Effective Date”) by and between Array BioPharma Inc., a Delaware corporation (“Array”), and ASLAN Pharmaceuticals, a Singapore corporation (“ASLAN”, as further defined below). Each of Array and ASLAN are sometimes referred to herein as a “Party” or, collectively, as the “Parties”.
LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE, LTD AND ARRAY BIOPHARMA INC.License Agreement • November 2nd, 2011 • Array Biopharma Inc • Pharmaceutical preparations • Delaware
THIS LICENSE AGREEMENT (“Agreement”) is made and entered into, effective as of August 5, 2011 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“GNE”); F. Hoffmann-La Roche, Ltd, having a principal place of business at Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche together referred to as “Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”). Genentech and Array are each referred to, individually, as a “Party” and, collectively, as the “Parties.”
